Hardik Desai Family Trust has acquired 15,000 equity shares of Trident Texofab in the open market. The transaction, executed on August 20, 2026, represents a 0.10% increase in the trust’s holding relative to the company’s total voting capital.

The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The Hardik Desai Family Trust is categorized as part of the promoter group.

Transaction Details

The acquisition was made through open market purchases. Prior to this transaction, the trust held 10,18,691 shares, representing a 6.79% stake in Trident Texofab. Following the purchase of 15,000 additional shares, the total holding stands at 10,33,691 shares, or 6.89% of the equity share capital.

The company’s total equity share capital remains unchanged at ₹14,99,57,640, comprising 1,49,95,764 equity shares with a face value of ₹10 each. There were no changes to diluted share capital or voting rights other than those carried by the acquired shares.

The Hardik Desai Family Trust, identified as part of the promoter group of Trident Texofab , acquired an additional stake in the textile manufacturer through the open market. The trust purchased 39,425 equity shares on August 17, 2026, representing a 0.26% increase in its voting power relative to the total share capital.

Following this acquisition, the trust’s total holding stands at 10,18,691 shares, which accounts for 6.79% of the company’s total voting capital. Prior to this transaction, the entity held 9,79,266 shares, constituting a 6.53% stake. The disclosure was filed with BSE Limited on August 20, 2026, in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Shareholding Structure

The acquisition was conducted entirely through the open market mechanism. The disclosure indicates no changes to the company’s total equity share capital, which remains at Rs. 14,99,57,640 (1,49,95,764 equity shares of Rs. 10 each). There were no warrants, convertible securities, or other instruments entitling the acquirer to receive shares carrying voting rights involved in this transaction.

Regulatory Compliance

The filing was submitted by Hardik Jigishkumar Desai, acting as trustee for the Hardik Desai Family Trust. The document confirms that the acquirer belongs to the promoter category and lists Trident Texofab Limited as the target company. The trust’s address is recorded as Seema Row House, Opp Krushi Farm, Ghod Dod Road, Umra, Surat.

No shares were reported as encumbered with pledge, lien, or non-disposal undertakings either before or after the acquisition. The total diluted share/voting capital of Trident Texofab remains unchanged at Rs. 14,99,57,640 post-transaction.